076213791	076213791	CD	B-NP	O
|	|	NN	I-NP	O
NH	NH	NN	I-NP	O
|	|	NN	I-NP	O
70011396	70011396	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9924177	9924177	CD	B-NP	O
|	|	CC	I-NP	O
3/10/2005	3/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/21/2005	8/21/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/16/2005	4/16/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
GREENLEAF	GREENLEAF	NN	B-NP	B-protein
,	,	,	O	O
MERLE	MERLE	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Medicine	Medicine	NNP	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
,	,	,	O	O
COPD	COPD	NNP	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
48-year-old	48-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	I-NP	O
COPD	COPD	NN	I-NP	O
and	and	CC	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
cold	cold	NN	B-NP	O
like	like	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
progressively	progressively	RB	B-ADVP	O
worsened	worsen	VBD	B-VP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sore	sore	JJ	I-NP	O
throat	throat	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
headache	headache	NN	I-NP	O
that	that	WDT	B-NP	O
progressed	progress	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
sputum-productive	sputum-productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
orthopnea	orthopnea	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
increasingly	increasingly	RB	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
requiring	require	VBG	B-VP	O
more	more	RBR	B-NP	O
frequent	frequent	JJ	I-NP	O
inhaler	inhaler	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
last	last	JJ	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
got	get	VBD	B-VP	O
azithromycin	azithromycin	NN	B-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
completed	complete	VBD	B-VP	O
antibiotic	antibiotic	JJ	B-NP	O
course	course	NN	I-NP	O
but	but	CC	B-PP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
has	have	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
even	even	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
works	work	VBZ	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
yesterday	yesterday	NN	B-NP	O
measured	measure	VBD	B-VP	O
her	her	PRP$	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
76	76	CD	B-NP	O
%	%	NN	I-NP	O
under	under	IN	B-PP	O
mild	mild	JJ	B-NP	O
exertion	exertion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
then	then	RB	B-ADVP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
today	today	NN	B-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
cough	cough	NN	B-NP	O
with	with	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
mild	mild	JJ	B-NP	O
subjective	subjective	JJ	I-NP	O
fevers	fever	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
chills	chill	NNS	I-NP	O
or	or	CC	O	O
no	no	DT	B-NP	O
night	night	NN	I-NP	O
sweats	sweat	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
headaches	headache	NNS	B-NP	O
and	and	CC	O	O
baseline	baseline	NN	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
FEV1/FVC	FEV1/FVC	NN	I-NP	O
of	of	IN	B-PP	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-VP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
hospitalized	hospitalize	VBN	I-VP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
intubated	intubate	VBN	B-VP	O
for	for	IN	B-PP	O
past	past	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
following	follow	VBG	B-VP	O
that	that	IN	B-SBAR	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
18	18	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
radiation	radiation	NN	I-NP	O
and	and	CC	I-NP	O
surgery	surgery	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Lasix	Lasix	CD	B-NP	O
40	40	CD	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
levothyroxine	levothyroxine	NN	I-NP	O
225	225	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
Xanax	Xanax	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Motrin	Motrin	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
20	20	CD	B-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Erythromycin	Erythromycin	NN	B-NP	O
and	and	CC	O	O
Flexeril	Flexeril	NNP	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
30-pack	30-pack	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
works	work	VBZ	B-VP	O
at	at	IN	B-PP	O
Colorado	Colorado	NNP	B-NP	O
FAMILY	FAMILY	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
99.2	99.2	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
86	86	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
153/88	153/88	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Exam	Exam	NNP	B-NP	O
,	,	,	O	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
pleasant	pleasant	JJ	B-NP	O
middle-aged	middle-aged	JJ	I-NP	O
woman	woman	NN	I-NP	O
sitting	sit	VBG	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
wheelchair	wheelchair	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
scleral	scleral	JJ	I-NP	O
icterus	icterus	NN	I-NP	O
.	.	.	O	O

Face	Face	NNP	B-NP	O
flushed	flush	VBD	B-VP	O
with	with	IN	B-PP	O
spider	spider	NN	B-NP	O
angioma	angioma	NN	I-NP	O
.	.	.	O	O

Mucosal	Mucosal	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
moist	moist	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
approximately	approximately	RB	B-NP	O
7	7	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
apex	apex	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
axilla	axilla	NN	B-NP	O
and	and	CC	O	O
laterally	laterally	RB	B-VP	O
displaced	displace	VBD	I-VP	O
PMI	PMI	NN	B-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
after	after	IN	B-PP	O
nebulizers	nebulizer	NNS	B-NP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
right	right	JJ	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
modestly	modestly	RB	I-NP	O
obese	obese	JJ	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Edema	Edema	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.6	4.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
14	14	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
105	105	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
4.6	4.6	CD	I-NP	I-cell_line
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
45.8	45.8	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
256	256	CD	B-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Coags	Coag	NNS	B-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
46	46	CD	I-NP	I-protein
,	,	,	O	O
CK-MB	CK-MB	NN	B-NP	B-protein
0.9	0.9	CD	I-NP	I-protein
,	,	,	O	O
troponins	troponin	NNS	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
T-wave	T-wave	NN	B-NP	O
inversions	inversion	NNS	I-NP	O
,	,	,	O	O
V3	V3	NN	B-NP	B-protein
through	through	IN	B-PP	O
V5	V5	NN	B-NP	B-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
shows	show	VBZ	B-VP	O
enlarged	enlarged	JJ	B-NP	O
heart	heart	NN	I-NP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
opacity	opacity	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
possible	possible	JJ	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
versus	versus	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
versus	versus	CC	O	O
exacerbation	exacerbation	NN	B-NP	O
versus	versus	CC	I-NP	O
COPD	COPD	NN	I-NP	O
versus	versus	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
counts	count	NNS	I-NP	O
but	but	CC	O	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypoxic	hypoxic	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
80s	80	NNS	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
with	with	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
.	.	.	O	O

Levaquin	Levaquin	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
doses	dose	NNS	I-NP	O
in-house	in-house	JJ	B-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
14-day	14-day	JJ	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PECT	PECT	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
read	read	VBN	I-VP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
read	read	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
given	give	VBN	I-VP	O
negative	negative	JJ	B-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Pulmonary	Pulmonary	NNP	B-NP	O
Service	Service	NNP	I-NP	O
who	who	WP	B-NP	O
performed	perform	VBD	B-VP	O
the	the	DT	B-NP	O
bronchoscopy	bronchoscopy	NN	I-NP	O
on	on	IN	B-PP	O
6/14/05	6/14/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
copious	copious	JJ	I-NP	O
blood-tinged	blood-tinged	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
and	and	CC	O	O
collapsed	collapse	VBD	B-VP	O
right	right	JJ	B-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
lung	lung	NN	I-NP	O
with	with	IN	B-PP	O
narrow	narrow	JJ	B-NP	O
orifice	orifice	NN	I-NP	O
.	.	.	O	O

Brushings	Brushing	NNS	B-NP	O
and	and	CC	I-NP	O
cytology	cytology	NN	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
Pathology	Pathology	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
showed	show	VBD	B-VP	O
severe	severe	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
FEV	FEV	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
restrictive	restrictive	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
bubble	bubble	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
septal	septal	JJ	I-NP	O
defects	defect	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
PA	PA	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
42	42	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
for	for	IN	B-PP	O
vasodilator	vasodilator	NN	B-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
heart	heart	NN	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
high	high	JJ	B-NP	O
right-sided	right-sided	JJ	I-NP	O
heart	heart	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
16-18	16-18	CD	B-NP	O
and	and	CC	O	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
left	left	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Ookter	Ookter	NNP	I-NP	O
Highway	Highway	NNP	I-NP	O
,	,	,	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
Hypertension	Hypertension	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
impressions	impression	NNS	I-NP	O
were	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
poor	poor	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
COPD	COPD	NN	B-NP	O
and	and	CC	I-NP	O
pectus	pectus	NN	I-NP	O
cavernosum	cavernosum	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
radiation	radiation	NN	B-NP	O
for	for	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
indication	indication	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
collapsed	collapse	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
2-3	2-3	NN	B-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
at	at	IN	B-PP	O
about	about	IN	B-NP	O
middle	middle	JJ	I-NP	O
90s	90	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
re-evaluated	re-evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
on	on	IN	B-PP	O
3/29/05	3/29/05	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
any	any	DT	B-NP	O
particular	particular	JJ	I-NP	O
treatments	treatment	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
2-3	2-3	CD	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
and	and	CC	O	O
instructed	instruct	VBN	B-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
O2	O2	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
above	above	IN	B-PP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
work	work	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
work	work	NN	I-NP	O
situation	situation	NN	I-NP	O
and	and	CC	I-NP	O
disability	disability	NN	I-NP	O
regarding	regard	VBG	B-PP	O
her	her	PRP$	B-NP	O
lung	lung	NN	I-NP	O
condition	condition	NN	I-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
complicating	complicate	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
JVP	JVP	NN	B-NP	B-protein
remained	remain	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
flat	flat	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
hypertensive	hypertensive	JJ	I-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
captopril	captopril	NN	B-NP	O
and	and	CC	O	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-VP	O
encourage	encourage	VB	I-VP	O
gentle	gentle	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
diet-controlled	diet-controlled	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
and	and	CC	I-NP	O
house	house	NN	I-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
only	only	RB	B-NP	O
several	several	JJ	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
100s	100	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Levoxyl	Levoxyl	NNP	B-NP	O
225	225	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	JJ	I-NP	O
in-house	in-house	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
increased	increase	VBN	I-NP	O
TSH	TSH	NN	I-NP	O
of	of	IN	B-PP	O
10.5	10.5	CD	B-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
dose	dose	NN	B-NP	O
of	of	IN	B-PP	O
Levoxyl	Levoxyl	NN	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
250	250	CD	B-NP	O
mcg	mcg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
recheck	recheck	VB	I-VP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
leg	leg	NN	B-NP	O
cramps	cramp	NNS	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
spasms	spasm	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Back	Back	RB	B-NP	O
pain	pain	NN	I-NP	O
appears	appear	VBZ	B-VP	O
chronic	chronic	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
spasms	spasm	NNS	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
musculoskeletal	musculoskeletal	JJ	B-ADJP	O
in	in	IN	B-PP	O
etiology	etiology	NN	B-NP	O
and	and	CC	O	O
not	not	RB	B-ADJP	O
cardiac	cardiac	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-ADVP	O
and	and	CC	O	O
then	then	RB	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
OxyContin	OxyContin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Social	Social	NNP	B-NP	O
Services	Service	NNPS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Social	Social	NNP	B-NP	O
Services	Service	NNPS	I-NP	O
regarding	regard	VBG	B-VP	O
prescription	prescription	NN	B-NP	O
coverage	coverage	NN	I-NP	O
,	,	,	O	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
handle	handle	VB	I-VP	O
copayments	copayment	NNS	B-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
concerns	concern	NNS	I-NP	O
regarding	regard	VBG	B-VP	O
short-term	short-term	JJ	B-NP	O
disability	disability	NN	I-NP	O
and	and	CC	O	O
long-term	long-term	JJ	B-NP	O
disability	disability	NN	I-NP	O
for	for	IN	B-PP	O
work	work	NN	B-NP	O
were	be	VBD	B-VP	O
addressed	address	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
inquire	inquire	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
benefit	benefit	NN	I-NP	O
office	office	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
for	for	IN	B-PP	O
services	service	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Discharged	Discharge	VBN	B-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Levaquin	Levaquin	NN	B-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
250	250	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Xanax	Xanax	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
OxyContin	OxyContin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
1-2	1-2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	VBP	B-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
if	if	IN	B-SBAR	O
becoming	become	VBG	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fever	fever	RB	B-ADVP	O
over	over	IN	B-PP	O
100.5	100.5	CD	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
or	or	CC	I-NP	O
questions	question	NNS	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
10/17/05	10/17/05	CD	B-NP	O
at	at	IN	B-PP	O
Bayhead	Bayhead	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
sleep	sleep	JJ	B-NP	O
study	study	NN	I-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
arrive	arrive	VB	I-VP	O
before	before	IN	B-PP	O
09	09	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
that	that	IN	B-NP	O
night	night	NN	B-NP	O
,	,	,	O	O
10/25/05	10/25/05	CD	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Chesterman	Chesterman	NNP	I-NP	O
at	at	IN	B-PP	O
02	02	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
for	for	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Hilse	Hilse	NNP	I-NP	O
on	on	IN	B-PP	O
7/18/05	7/18/05	CD	B-NP	O
at	at	IN	B-PP	O
04	04	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
for	for	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
issues	issue	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
'	'	POS	B-NP	O
time	time	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
regarding	regard	VBG	B-VP	O
her	her	PRP$	B-NP	O
thyroid	thyroid	JJ	I-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-1803670	5-1803670	CD	B-NP	O
CS	CS	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Berry	Berry	NNP	B-NP	O
Althoff	Althoff	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Scdi	Scdi	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Garl	Garl	NNP	I-NP	O
Ren	Ren	NNP	I-NP	O
Ley	Ley	NNP	I-NP	O
A	A	NNP	I-NP	O
Coln	Coln	NNP	I-NP	O
Eans	Eans	NNP	I-NP	O
Pe	Pe	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Walton	Walton	NNP	B-NP	O
Grady	Grady	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Division	Division	NNP	I-NP	O
,	,	,	O	O
Scotcoke	Scotcoke	NNP	B-NP	O
Reph	Reph	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
Mong	Mong	NNP	I-NP	O
Worth	Worth	NNP	I-NP	O
Sifontheights	Sifontheights	NNP	I-NP	O
,	,	,	O	O
WY	WY	NNP	B-NP	O
Pit	Pit	NNP	I-NP	O
War	War	NNP	I-NP	O
Yuwarknas	Yuwarknas	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Burchess	Burchess	NNP	B-NP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
MCCALPIN	MCCALPIN	NN	B-NP	O
,	,	,	O	O
TED	TED	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SALAZA	SALAZA	NNP	B-NP	O
,	,	,	O	O
EMILE	EMILE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0676572	0676572	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/19/05	4/19/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/19/05	4/19/05	CD	B-NP	O

